Evidence map›Paper›PMID 34920039›Full record

ArticleJournal of affective disorders2022

Prevalence and determinants of probable depression and anxiety during the COVID-19 pandemic in seven countries: Longitudinal evidence from the European COvid Survey (ECOS).

André Hajek, Iryna Sabat, Sebastian Neumann-Böhme, Jonas Schreyögg, Pedro Pita Barros, Tom Stargardt, Hans-Helmut König

Registry-linked trialAbstract read
In one paragraph

Article in Journal of affective disorders, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06124014 (Cranial Electrotherapy Stimulation), which is not on this map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06124014 nacompletednot on this mapstarted 2024, after this paper: background citation

Cranial Electrotherapy Stimulation (CES) for the Treatment of Generalized Anxiety Disorder (GAD) in Young Adults: Double-Blind Sham-Controlled Randomized Clinical Trial

TypeinterventionalSponsorElectromedical Products International, Inc.Ran2024 to 2026Enrolled130ConditionsGeneralized Anxiety DisorderArmsAt-Home Stimulation
3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Does timing matter? The role of health information shocks in measuring willingness to pay.The European journal of health economics : HEPAC : health economics in prevention and care · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Braving the waves: exploring capability well-being patterns in seven European countries during the COVID-19 pandemic.The European journal of health economics : HEPAC : health economics in prevention and care · 2024
    Observational
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Fear of war and mental health in Germany.Social psychiatry and psychiatric epidemiology · 2023
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

André HajekDepartment of Health Economics and Health Services Research, University Medical Center Hamburg-Eppendorf, Hamburg Center for Health Economics, Hamburg, Germany. Electronic address: a.hajek@uke.de.
Iryna SabatNova School of Business and Economics, Portugal.
Sebastian Neumann-BöhmeErasmus School of Health Policy and Management, Erasmus University Rotterdam, The Netherlands.
Jonas SchreyöggHamburg Center for Health Economics, University of Hamburg, Germany.
Pedro Pita BarrosNova School of Business and Economics, Portugal.
Tom StargardtHamburg Center for Health Economics, University of Hamburg, Germany.
Hans-Helmut KönigDepartment of Health Economics and Health Services Research, University Medical Center Hamburg-Eppendorf, Hamburg Center for Health Economics, Hamburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOur aim was to present data on the prevalence of probable depression and anxiety and to determine their correlates during the COVID-19 pandemic in seven European countries using a longitudinal approach.

methodsLongitudinal data (wave 4 in November 2020: n = 7,115; wave 5 in January 2021: n = 7,068; wave 6 in April 2021: n = 7,204) were taken from the European COvid Survey (ECOS), a representative sample of non-institutionalized inhabitants from Germany, United Kingdom, Denmark, Netherlands, France, Portugal and Italy aged 18+. Probable depression and anxiety were quantified using the established and validated PHQ-4 (2-item depression scale, PHQ-2 / 2-item anxiety scale, GAD-2).

resultsIn wave 4 (wave 5; wave 6), 26.6% (25.5%; 23.8%) of all respondents had probable depression and 25.7% (23.6%; 22.1%) had probable anxiety. Prevalence rates for probable depression and probable anxiety differed significantly between countries. Among all countries and waves, particularly high prevalence rates were found among individuals aged 18 to 29 years. Longitudinal analysis showed that the likelihood of probable depression was positively associated with increasing age, great income difficulties and lower health-related quality of life. The likelihood of probable anxiety was positively associated with income difficulties, and lower health-related quality of life. LIMITATIONS: Screening tool was used to quantify the outcomes.

conclusionThe magnitude of probable depression and anxiety during the COVID-19 pandemic in European countries was highlighted. Moreover, determining the factors associated with probable depression or anxiety (e.g., income difficulties, worse health-related quality of life) may assist in identifying individuals at increased risk.

Indexed as

COVID-19DepressionAnxietyCross-Sectional StudiesHumansPandemicsPatient Health QuestionnairePrevalenceQuality of LifeSARS-CoV-2AnxietyCoronavirusCOVID-19DepressionMental disordersMental illnessPatient Health Questionnaire (PHQ)PrevalenceSARS-CoV-2

Identifiers

PMID34920039
PMCPMC8684990

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.